Anti‐inflammatory effects of resolvins in diabetic nephropathy: Mechanistic pathways. Issue 9 (11th February 2019)

• Record Type: Journal Article
• Authors: Yaribeygi, Habib; Atkin, Stephen L.; Simental‐Mendía, Luis E.; Barreto, George E.; Sahebkar, Amirhossein
• Is Part Of: Journal of cellular physiology. Volume 234:Issue 9(2019:Sep.)
• Page Start: 14873
• Page End: 14882
• Publication Date: 2019-02-11
• Subjects: diabetic nephropathy -- inflammation -- NF‐κB -- oxidative stress -- resolvin D1 -- resolvin E1; Physiology -- Periodicals; Cell physiology -- Periodicals; 571.6
• DOI: 10.1002/jcp.28315
• Languages: English
• ISSNs: 0021-9541

Abstract

Abstract: The incidence of diabetes mellitus is growing rapidly. The exact pathophysiology of diabetes is unclear, but there is increasing evidence of the role of the inflammatory response in both developing diabetes as well as its complications. Resolvins are naturally occurring polyunsaturated fatty acids that are found in fish oil and sea food that have been shown to possess anti‐inflammatory actions in several tissues including the kidneys. The pathways by which resolvins exert this anti‐inflammatory effect are unclear. In this review we discuss the evidence showing that resolvins can suppress inflammatory responses via at least five molecular mechanisms through inhibition of the nucleotide‐binding oligomerization domain protein 3 inflammasome, inhibition of nuclear factor κB molecular pathways, improvement of oxidative stress, modulation of nitric oxide synthesis/release and prevention of local and systemic leukocytosis. Complete understanding of these molecular pathways is important as this may lead to the development of new effective therapeutic strategies for diabetes and diabetic nephropathy. Abstract : Resolvins are naturally occurring polyunsaturated fatty acids that are found in fish oil and sea food that have been shown to possess anti‐inflammatory actions in several tissues including the kidneys. The pathways by which resolvins exert this anti‐inflammatory effect are unclear. In this review we discuss the evidence showing that resolvins can suppress inflammatory responses via at least five molecular mechanisms through inhibition of the nucleotide‐binding oligomerization domain protein 3 inflammasome (NLRP3i), inhibition of nuclear factor κB (NF‐κB) molecular pathways, improvement of oxidative stress, modulation of nitric oxide (NO) synthesis/release, and prevention of local and systemic leukocytosis.